Rare diseases
Investigational molecules
Locations
Back to Hungary110 clinical trials in Gyongyos, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
HungaryPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
HungaryEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
HungaryLong‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis
HungaryA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
HungaryEIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer
HungaryPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
HungaryComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
HungaryA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
HungaryA study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
HungaryLong-Term Safety Study of Direclidine in Adults with Schizophrenia
HungaryA study testing direclidine compared to placebo in adults with schizophrenia who need hospital care
HungaryThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for non-small cell lung cancer (NSCLC) and chronic respiratory conditions, with multiple trials evaluating new immunotherapy combinations and targeted therapies.
Several trials are exploring combination therapies to improve patient outcomes in advanced stages of lung cancer.
Comprehensive studies on inflammatory and autoimmune disorders, including psoriasis and inflammatory bowel diseases, testing novel therapeutic approaches.
Multiple trials are evaluating new biological therapies for moderate to severe cases of these conditions.
Innovative studies targeting heart failure prevention and cardiovascular disease management, with a focus on reducing major adverse cardiac events.
Research includes novel therapeutic combinations and preventive strategies for high-risk patients.
Clinical research focusing on Alzheimer's Disease and associated conditions, particularly investigating treatments for psychosis symptoms.
Trials are evaluating new therapeutic approaches for managing neuropsychiatric symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
